StockCIK 925741

BioCardia, Inc. (BCDA): Insider Trades and Fund Holdings

In the past 12 months, BioCardia, Inc. insiders reported 7 open-market purchases worth $11K and 0 sales worth $0.

7Insider buys, 12 months

$11KBought by insiders, 12 months

$0Sold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 20, 2026.

Recent BCDA insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 20	Oct 16	Peter AltmanCEO	CEO	▲ BUY	300	0.95	$285	+0.1%	Form 4 ↗
Oct 20	Oct 15	Peter AltmanCEO	CEO	▲ BUY	200	0.95	$190	+0.1%	Form 4 ↗
Sep 30	Sep 29	Peter AltmanCEO	CEO	▲ BUY	1,000	1.03	$1K	+0.3%	Form 4 ↗
Sep 23	Sep 23	Peter AltmanCEO	CEO	▲ BUY	1,900	1.05	$2K	+0.5%	Form 4 ↗
Sep 4	Sep 3	Peter AltmanCEO	CEO	▲ BUY	800	1.09	$872	+0.2%	Form 4 ↗
Aug 18	Aug 17	Peter AltmanCEO	CEO	▲ BUY	5,400	0.93	$5K	+1.4%	Form 4 ↗
Aug 13	Aug 13	Peter AltmanCEO	CEO	▲ BUY	1,900	0.92	$2K	+0.5%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Peter Altman	CEO	7	$11K	0	$0	Oct 20, 2026

Tracked funds that report BCDA

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	0	$0	0.00%	▼ Sold out

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →